Assignment of antigenic determinants to separated I-A kappa chains

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Class II Major Histocompatibility Complex (MHC) antigens play crucial roles in immune responses.
• Tumor-derived antigens are often studied to understand cancer biology and develop therapies.
• Characterizing the structure and determinants of specific antigens is key to understanding immune recognition.

Purpose of the Study:

• To isolate and characterize the alpha- and beta-chains of the I-A kappa antigen from a B cell lymphoma (AKTB-1b).
• To localize specific alloantigenic determinants to either the A alpha kappa or A beta kappa chains.
• To compare the I-A kappa antigen from the lymphoma with that from normal tissue.

Main Methods:

• Separation of I-A kappa antigen chains using ion-exchange chromatography on CM-Sephadex.
• Denaturant removal via dialysis to allow refolding of isolated chains.
• Direct binding assays with monoclonal antibodies to map antigenic determinants.
• Tryptic peptide analysis for structural comparison.

Main Results:

• Isolated alpha- and beta-chains regained significant native configuration after denaturant removal.
• Specific alloantigenic determinants, including Ia.17 and part of Ia.2, were localized to the A beta kappa chain.
• Tryptic peptide analysis demonstrated the I-A kappa antigen from the lymphoma is identical to that from normal B10.BR splenocytes.

Conclusions:

• The study successfully isolated and characterized polypeptide chains of the I-A kappa antigen.
• Specific antigenic determinants were assigned to the A beta kappa chain.
• This research provides the first evidence that a tumor-derived class II MHC antigen shares identical polypeptide structure with its normal tissue counterpart.